Takeda on Tuesday said it has agreed to acquire an experimental autoimmune disease drug from Nimbus Therapeutics in one of the most valuable biotechnology licensing deals in recent years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,